Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,000
Closed -$199K 320
2024
Q1
$199K Hold
15,000
0.06% 226
2023
Q4
$204K Sell
15,000
-3,500
-19% -$46.4K 0.06% 224
2023
Q3
$281K Sell
18,500
-9,600
-34% -$177K 0.1% 191
2023
Q2
$738K Buy
28,100
+25,800
+1,122% +$569K 0.26% 99
2023
Q1
$47.7K Sell
2,300
-1,900
-45% -$28.5K 0.02% 224
2022
Q4
$43.3K Hold
4,200
0.02% 241
2022
Q3
$32K Hold
4,200
0.02% 253
2022
Q2
$29K Hold
4,200
0.01% 264
2022
Q1
$45K Hold
4,200
0.02% 252
2021
Q4
$53K Buy
+4,200
New +$54.4K 0.02% 241

Other funds holding INTT

Denali Advisors's INTT Position: Q2 2024 in Review

Denali Advisors sold out of inTEST (INTT) in Q2 2024, closing a stake of 15,000 shares — an estimated $199K sold.

Denali Advisors first reported a position in INTT in Q4 2021 and held it in 10 quarters. The position peaked at $738K in Q2 2023. 75 funds tracked by Wall St. Rank hold INTT as of Q2 2024.

  • Denali Advisors reported no remaining inTEST position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 15,000 inTEST shares in Q2 2024, an estimated $199K.
  • Denali Advisors first reported a position in inTEST in Q4 2021 and held it in 10 quarters.
  • Denali Advisors's inTEST position peaked at $738K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held inTEST as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.